Jazz Pharmaceuticals plc


Jazz Pharma Scores Surprise Early Approval For Lung Cancer Treatment

Jazz Pharmaceuticals (JAZZ) and partner PharmaMar have announced a surprise early approval from the US FDA for its Zepzelca treatment for adults with …

First Patient Enrolled in Jazz Pharmaceuticals plc (JAZZ) Phase 3 Trial of Defibrotide for the Potential Prevention of VOD

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced that the first patient has been enrolled in a Phase 3 clinical trial comparing the efficacy and safety …

Mizuho Analyst Raises Price Target for Jazz Pharmaceuticals plc (JAZZ)

Analyst Irina Koffler from Mizuho Securities reiterated her Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) with a raised price target of $195, marking …

Stock Update (NASDAQ:CPXX): Celator Pharmaceuticals Inc and Jazz Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share

Celator Pharmaceuticals Inc (NASDAQ:CPXX) and Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced that they have entered into a definitive agreement for Jazz Pharmaceuticals to acquire Celator …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts